101657121
liked
2
101657121
commented on
$Heidmar Maritime Holdings (HMR.US)$
Those who sold before the conversion during pre market, what is the status now? Still having problem or fixed?
Those who sold before the conversion during pre market, what is the status now? Still having problem or fixed?
1
14
101657121
commented on
$Heidmar Maritime Holdings (HMR.US)$ i think they are selling internally first, setting up the opening price😅
3
2
101657121
liked
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY,...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY,...
63
9
1
101657121
commented on
$Regulus Therapeutics (RGLS.US)$
Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429)
Wednesday, 29th January at 7:00 am
Topline data from an interim analysis of the fourth cohort of its Phase 1b Multiple-Ascending Dose (MAD) clinical trial showed continued mechanistic dose response
Exploratory results of imaging-based biomarkers continued to show reduction in height-adjusted tot...
Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429)
Wednesday, 29th January at 7:00 am
Topline data from an interim analysis of the fourth cohort of its Phase 1b Multiple-Ascending Dose (MAD) clinical trial showed continued mechanistic dose response
Exploratory results of imaging-based biomarkers continued to show reduction in height-adjusted tot...
1
3
101657121
commented on
$MicroCloud Hologram (HOLO.US)$ anyone trap on 2.5?
2
101657121
reacted to
$Know Labs (KNW.US)$ i have intel with a agent he knows a friend that haves a friend that has a friend talks about this is going to hit 100 soon 🙌👐👐🗣️
5
2
101657121
liked
Fair value gap spotted.
If price goes below the fair value gap, instead of reacting to it, it might mean a trend reversal as sellers took control or a weakening of a bullish trend.
If price goes above, it means a continuation of the bull trend or a creation of a new FVG if there is a strong price movement.
$XRP (XRP.CC)$
If price goes below the fair value gap, instead of reacting to it, it might mean a trend reversal as sellers took control or a weakening of a bullish trend.
If price goes above, it means a continuation of the bull trend or a creation of a new FVG if there is a strong price movement.
$XRP (XRP.CC)$

4
5
1
101657121
liked
$Simpple (SPPL.US)$
SIMPPLE Ltd. CEO Issues Letter to Shareholders
Friday, 10th January at 8:30 am
Singapore, Jan. 10, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) ("SIMPPLE" or "the Company"), a leading technology provider and innovator in the facilities management (FM) sector, today announced that Norman Schroeder, the Company's Chief Executive Officer, has issued the following Letter to Shareholders.
Dear Shareholders:
As we reflect and assess the year that has been, I would like t...
SIMPPLE Ltd. CEO Issues Letter to Shareholders
Friday, 10th January at 8:30 am
Singapore, Jan. 10, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) ("SIMPPLE" or "the Company"), a leading technology provider and innovator in the facilities management (FM) sector, today announced that Norman Schroeder, the Company's Chief Executive Officer, has issued the following Letter to Shareholders.
Dear Shareholders:
As we reflect and assess the year that has been, I would like t...
1